Simplex Trading, LLC Renalytix PLC Transaction History

Simplex Trading, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$0.33 - $1.61 $7 - $35	22 New	22 $0
Q2 2023 Aug 04, 2023	BUY	$2.0 - $2.92 $4,320 - $6,307	2,160 Added 46.44%	6,811 $19,000
Q1 2023 Apr 27, 2023	SELL	$1.93 - $3.72 $4,979 - $9,597	-2,580 Reduced 35.68%	4,651 $11,000
Q4 2022 Feb 02, 2023	BUY	$1.06 - $2.21 $2,712 - $5,655	2,559 Added 54.77%	7,231 $13,000
Q3 2022 Nov 04, 2022	BUY	$1.19 - $2.78 $784 - $1,832	659 Added 16.42%	4,672 $5,000
Q2 2022 Aug 03, 2022	SELL	$2.45 - $7.81 $36,166 - $115,291	-14,762 Reduced 78.63%	4,013 $9,000
Q1 2022 May 02, 2022	SELL	$5.88 - $15.9 $3,369 - $9,110	-573 Reduced 2.96%	18,775 $129,000
Q4 2021 Feb 23, 2022	BUY	$13.43 - $27.4 $259,843 - $530,135	19,348 New	19,348 $307,000

554K

Ticker RNLX
Exchange OTC
Sector Healthcare
Industry Health Information Services
Shares Outstandng 37,445,900
Market Cap $5.62M
Description
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.